SEC Filing Summary: Second Sight Medical Products, Inc.
Business Context and Reporting Period
This Form 8-K was filed by Second Sight Medical Products, Inc. on October 25, 2016. The filing serves as a Regulation FD disclosure to distribute investor presentation materials intended for use at the MicroCap Conference held on the same date in Philadelphia. The registrant is incorporated in California and operates from Sylmar, California.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document solely discloses the existence of attached presentation materials (Exhibit 99.1) and does not contain a financial statement or tabular data within the body of the report.
Material Changes
No material changes to financial performance or operations are reported in this specific filing. The document is a procedural disclosure to ensure equal access to information presented to investors at a conference.
Guidance, Outlook, and Risks
Management commentary is limited to the disclaimer that the attached presentation materials speak as of the date of the report. Second Sight explicitly disclaims any obligation to update these materials in the future or to reflect events occurring after October 25, 2016. The filing notes that the information contained herein shall not be deemed "filed" for purposes of Section 18 of the Exchange Act unless expressly incorporated by reference in another filing.
Key Facts for Investor Verification
- Verify the contents of Exhibit 99.1 (Investor Presentation dated October 2016) for actual financial data and strategic outlook, as the 8-K body does not contain these figures.
- Confirm that the presentation materials are not considered "filed" under Section 18 of the Exchange Act, limiting their legal liability status compared to standard financial reports.
- Note the explicit disclaimer that the company is under no obligation to update the information provided in the presentation materials.